Skip to content
glogofinal
  • About Us
  • Research & Development
    • Our Approach
    • Innovative Pipeline
    • Research Centers
  • Partnership Opportunities
  • Products
  • News / Media
  • Contact
Menu Close
  • About Us
  • Research & Development
    • Our Approach
    • Innovative Pipeline
    • Research Centers
  • Partnership Opportunities
  • Products
  • News / Media
  • Contact

News / Media

Year 2025

  • GLENMARK Pharmaceuticals Australia Launches ZONOFADE™
    A Scientifically Formulated Diabetes Skincare Range to Nourish, Protect & Restore Skin Health
  • Glenmark Pharmaceuticals (Australia) Launches ATOVACUE (Atovaquone) Oral Liquid Suspension 750mg in 5mL

Year 2024

  • Glenmark Pharmaceuticals Launches SUPIROCIN™ (Mupirocin) Antibacterial Cream in Australia, Marking a Milestone in Expansion Strategy
  • Copyright 2025 – Glenmark Pharmaceuticals – Australia
  • Terms & Conditions
  • Privacy Notice
  • Privacy Portal
  • Copyright 2025 – Glenmark Pharmaceuticals – Australia
  • Terms & Conditions
  • Privacy Notice
Privacy Portal

Alert

You are now leaving the Glenmark Australia website domain and being redirected to a Glenmark Pharma website. Please note that the website is third party owned and access to this site will be subject to the cookie, privacy and legal policies of the third party.

  • Terms & Conditions
  • Privacy Notice
Privacy Portal

Alert

You are now leaving the Glenmark Australia website domain and being redirected to a Glenmark Pharma website. Please note that the website is third party owned and access to this site will be subject to the cookie, privacy and legal policies of the third party.

  • Copyright 2025 – Glenmark Pharmaceuticals – Australia